A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor

J Clin Pharmacol. 2011 Aug;51(8):1241-6. doi: 10.1177/0091270010381901. Epub 2011 Jan 5.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drugs, Investigational / administration & dosage
  • Drugs, Investigational / adverse effects*
  • Drugs, Investigational / analysis
  • Drugs, Investigational / pharmacokinetics
  • Electrocardiography / drug effects*
  • Factor Xa Inhibitors*
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects*
  • Fibrinolytic Agents / blood
  • Fibrinolytic Agents / pharmacokinetics
  • Half-Life
  • Humans
  • Male
  • Pyridines / administration & dosage
  • Pyridines / adverse effects*
  • Pyridines / blood
  • Pyridines / pharmacokinetics
  • Thiazoles / administration & dosage
  • Thiazoles / adverse effects*
  • Thiazoles / blood
  • Thiazoles / pharmacokinetics
  • Young Adult

Substances

  • Drugs, Investigational
  • Factor Xa Inhibitors
  • Fibrinolytic Agents
  • Pyridines
  • Thiazoles
  • edoxaban